Author:
Di Ruscio A,Patti F,Welner R S,Tenen D G,Amabile G
Abstract
Abstract
Human induced pluripotent stem (iPS) cells can be derived from lineage-restricted cells and represent an important tool to develop novel patient-specific cell therapies and research models for inherited and acquired diseases. Recently, patient-derived iPS cells, containing donor genetic background, have offered a breakthrough approach to study human genetics of neurodegenerative diseases. By offering an unlimited source of patient-specific disease-relevant cells, iPS cells hold great promise for understanding disease mechanisms, identifying molecular targets and developing phenotypic screens for drug discovery. This review will discuss the potential impact of using iPS cell-derived models in multiple sclerosis (MS) research and highlight some of the current challenges and prospective for generating novel therapeutic treatments for MS patients.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference66 articles.
1. Nylander A, Hafler DA . Multiple sclerosis. J Clin Invest 2012; 122: 1180–1188.
2. Ebers GC . Environmental factors and multiple sclerosis. Lancet Neurol 2008; 7: 268–277.
3. Donati D, Jacobson S . Virus and multiple sclerosis. In: Brogden KA, Guthmiller JM (eds). Polymicrobial Diseases. ASM Press: Washington, DC, USA, 2002; Chapter 6, pp 1–49.
4. Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009; 132: 3318–3328.
5. Goldberg P . Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence. Int J Environ Studies 1974; 6: 121–129.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献